La farmacéutica Pfizer planea combinar su rama de medicamentos libres de patente, que incluye las píldoras para el colesterol Lipitor y el medicamento para la impotencia masculina Viagra, con su similar Mylan NV y formar un nuevo gigante en el sector de medicamentos genéricos.
Featured News
Tesla, Hertz and Uber Face Antitrust Suit Over $4.2B Electric-Vehicle Deal
Nov 18, 2026 by
CPI
Simpson Thacher Adds Five Partners to Litigation Practice
Nov 18, 2026 by
CPI
US Senators Press White House for Urgent Action as AI Cyber Risks Outpace Defenses
Nov 18, 2026 by
CPI
Brazil Pushes Back Against EU Scrutiny of Anglo American Nickel Deal
Nov 18, 2026 by
CPI
South Korea’s KFTC Seeks Tougher Fines, Raising Search Power Concerns
Nov 18, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Data Portability
Nov 12, 2026 by
CPI
Mandating Access to a Dominant Platform’s Inferred Data: A Two Scenario Diagnosis
Nov 12, 2026 by
Sean Ennis
Data Portability Between Individual Control and Data Sharing at Scale
Nov 12, 2026 by
Jasper van den Boom & Inge Graef
Information Also Wants to Be Expensive: Data Portability and the Open-Systems Creed
Nov 12, 2026 by
Justin (Gus) Hurwitz
Data Portability’s Cybersecurity Paradox: When Protecting Consumer Data Restricts Competition
Nov 12, 2026 by
Sasha Hondagneu-Messner